OSNA Neoadjuvant Feasibility Study in Breast Cancer Patients
Observational Model: Case-Only, Time Perspective: Prospective
Prospectively assess the performance of the OSNA Breast Cancer System for the detection of SLN metastasis in subjects treated with neoadjuvant therapy prior to SLN biopsy by comparing results with standard histopathology evaluation.
United States: Institutional Review Board
|Arizona Cancer Center||Tucson, Arizona 85724|
|University of Texas MD Anderson Cancer Center||Houston, Texas 77030|